Skip to main content

Table 1 Study and participant characteristics

From: Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review

Study

Study Design

Study Year

n

Population

Location

Age in years

PUBLISHED LITERATURE

     

Mean ± SD or (range)

Ochnio 2005* [22]

P

2000–1

811

Grade 9 students

British Columbia

(14–15)

Muecke 2004* [23]

CC

2001

492

Day-care educators

Montreal

37

Minuk 2003 [24]

P

1999

315

First Nations

Manitoba

34 ± 15

Ochnio 2001 [25]

P

1998

494

Street youth, IDU, MSM

Vancouver

19, 35, 34

Smieja 2001 [26]

CC

1997–8

179

IHD patients

Hamilton

61 (38–81)

Kiefer 2000 [27]

R

1997

343

Hepatitis C patients

Edmonton

40 (0–95)

Allard 2001 [28]

P

1995–97

353

Gay men

Montreal

37

Moses 2002 [29]

P

1995–6

533

Street people

Winnipeg

26 (11–65)

Roy 2002 [30]

R

1995–6

427

Street youth

Montreal

(14–25)

Ochnio 1997 [31]

P

1995–6

224

Grade 6 students

Vancouver

(10–12)

De Serres 1997 [32]

P

1995

85

Sewer workers

Quebec

36 ± 7

De Serres 1995 [33]

CC

1995

228

Sewer workers

Quebec

41 (28–64)

Smieja 2003 [34]

R

1993–5

3127

CV or high risk diabetes

Canada

65

Payment 1991 [18]

P

1988–9

617

French-Canadian

Montreal

(9–79)

Embil 1989 [35]

P

1981–3

2036

1922

1/CF recruits

2/CF males

Nova Scotia, Quebec, Posted abroad

1/(15–25)

2/26 (17–53)

Nicolle 1986 [36], Minuk 1985 [37]

P

1982

172

Chesterfield Inlet

Northwest Territories

0 – 78

Crewe 1983 [38]

P

1981–2

304

Children attending outpatient clinic

Halifax

(0.5–16)

Minuk 1982 [39]

Minuk 1982 [40]

P

1980

720

Inuit

Northwest Territories

(0.3–86)

McFarlane 1980 [41]

P, R

1980

243

152

293 & 282

1/STD clinic patients

2/Student nurses

3/2 groups of blood donors

Nova Scotia

1/(16–26)

2/(18–24)

3/(16–26) & (51–65)

Buchner 1980 [42]

R

1980

5097

Blood donors

Toronto

<21, >60

Richer 1982 [55]

R

1970–79

447

Samples of acute viral hepatitis

Montreal

Not reported

Minuk 1994 [43]

P

1974–8

42

Household transmission

Winnipeg

27 ± 12

Minuk 2003 [44]

SR

1980–2000

1706

Inuit and First Nations

Various locations

0–60+

McFarlane 1982 [45]

P

NR

154

Institutions

Nova Scotia

(13–28)

McFarlane 1981 [46]

P

NR

130

Patients with hematological malignancy

Nova Scotia

(4–76)

GREY LITERATURE

      

Duval 2005* [48]

P

2003

1057

Canadian aged 8–13

Canada

(8–13)

Wu 2005 [47]

R

1992–9

NR

Subjects tested for HAV infection

Manitoba

Not reported

Ochnio 2004 [49]

P

2003

585

Young adults

Vancouver

(20–39)

Cook 2000 [19]

R

2000

1206

Women of child-bearing age

British Columbia

(15–44)

Harb 2000 [50]

P

1999

172

First Nations

British Columbia

(0–40+)

Levy 2001 [51]

P

1997

1000

University students

Toronto

25 ± 5

Ford-Jones 1995 [52]

P

1993

122

Day-care providers

Toronto

Not reported

Ochnio 1995 [53]

P

1994–5

1019

Clients to travel clinic

Vancouver

(2–69+)

Kocuipchyk 1995 [54]

P

1991–2

505

Individuals attending travel clinic

Edmonton

(16–60+)

  1. Notes:*Study reported seroprevalence data for individuals with or without HAV vaccination.
  2. Abbreviations: Study design: P prospective data acquisition, R retrospective data acquisition, CC case control, SR systematic review. Population: IDU injection drug users, MSM men who have sex with men, IHD ischemic heart disease, CV cardiovascular, CF Canadian Forces, STD sexually transmitted disease.